U.S. market Closed. Opens in 8 hours 22 minutes

CNCR | Loncar Cancer Immunotherapy ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
TIL Instil Bio, Inc. 79.89M 3.59%
12.18 -5.21% 576.12% 75.97%
REPL Replimune Group, Inc. 752.82M 3.54%
9.78 -0.05% 122.01% 14.82%
IOVA Iovance Biotherapeutics, Inc. 1.11B 3.47%
3.38 -5.99% 130.38% 48.84%
ZYME Zymeworks Inc. 907.28M 3.45%
13.04 0.23% 291.26% 58.93%
ARGX argenx SE 38.99B 3.42%
638.49 -1.03% 31.77% 32.51%
GMAB Genmab A/S 13.06B 3.42%
20.94 -1.02% 74.56% 44.67%
AZN AstraZeneca PLC 435.69B 3.39%
70.27 -2.12% 34.59% 53.90%
BMY Bristol-Myers Squibb Company 101.08B 3.39%
49.67 -1.06% 42.70% 60.71%
CRSP CRISPR Therapeutics AG 3.25B 3.39%
37.69 -2.55% 66.84% 64.32%
MRK Merck & Co., Inc. 210.02B 3.37%
83.46 -2.04% 41.05% 63.29%
NKTR Nektar Therapeutics 143.49M 3.37%
0.7710 -3.08% 288.36% 62.82%
XNCR Xencor, Inc. 770.22M 3.37%
10.83 -1.77% 81.40% 44.47%
REGN Regeneron Pharmaceuticals, Inc. 62.34B 3.36%
582.91 -2.65% 49.81% 76.60%
FATE Fate Therapeutics, Inc. 140.39M 3.33%
1.2250 -4.30% 236.51% 49.41%
GILD Gilead Sciences, Inc. 129.85B 3.33%
104.16 -2.23% 38.50% 61.83%
RCUS Arcus Biosciences, Inc. 898.96M 3.32%
8.49 -2.97% 286.49% 39.78%
ATRA Atara Biotherapeutics, Inc. 46.55M 3.30%
7.81 -2.27% 769.79% 94.72%
ALLO Allogene Therapeutics, Inc. 359.57M 3.29%
1.6550 -1.49% 677.77% 87.88%
RUBY Rubius Therapeutics, Inc. 3.29%
TRIL Trillium Therapeutics Inc. 3.29%
BLUE bluebird bio, Inc. 40.38M 3.28%
4.13 1.10% 122.15% 11.34%
IBRX ImmunityBio, Inc. 2.16B 3.28%
2.4450 -2.59% 162.94% 80.02%
IMAB I-Mab 74.07M 3.25%
0.9089 -3.31% 546.25% N/A
IGMS IGM Biosciences, Inc. 79.20M 3.23%
1.3250 -4.33% 187.84% 100.00%
STTK Shattuck Labs, Inc. 49.82M 3.23%
1.0400 5.16% 586.39% 69.64%
ALXO ALX Oncology Holdings Inc. 27.90M 3.21%
0.5226 -3.22% 270.19% 41.68%
LEGN Legend Biotech Corporation 3.15B 3.20%
34.34 -1.75% 65.05% 22.04%
BGNE BeiGene, Ltd. 3.19%
MGNX MacroGenics, Inc. 106.62M 3.17%
1.6900 -2.59% 120.94% 50.24%
YMAB Y-mAbs Therapeutics, Inc. 184.49M 3.12%
4.08 -4.00% 299.13% 61.45%
Cash&Other 0.13%
Total holdings: 31 Recognized Stocks: 27 Others: 4
An error has occurred. This application may no longer respond until reloaded. Reload 🗙